Linked Life Data

21609384

Source:http://linkedlifedata.com/resource/pubmed/id/21609384

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-5-25
pubmed:abstractText
Despite advances in the treatment of heart failure (HF), which have resulted in improved survival, overall prognosis continues to be poor. Given the high short-term mortality rate, it remains important to utilize assessment techniques with established prognostic value in this patient population. Ideally, a given assessment should also be able to accurately reflect disease severity, a heterogeneous phenomenon in patients with HF, and accurately reflect the magnitude of physiologic/clinical improvement following the implementation or titration of an intervention. Cardiopulmonary exercise testing (CPX) satisfies all of the aforementioned desirable assessment attributes. Peak oxygen consumption and the minute ventilation/carbon dioxide production slope are key CPX variables in assessing prognosis and gauging disease severity. Given the high value of information obtained from this procedure, CPX should be considered a core assessment in the HF population. The current review will concisely define key CPX variables and summarize their clinical applications in patients with HF.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1751-7133
pubmed:author
pubmed:copyrightInfo
© 2011 Wiley Periodicals, Inc.
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
115-9
pubmed:meshHeading
pubmed:articleTitle
Cardiopulmonary exercise testing is a core assessment for patients with heart failure.
pubmed:affiliation
Physical Therapy Program, Department of Orthopaedics and Rehabilitation, School of Medicine, University of New Mexico, Albuquerque, NM 87131-0001, USA. rarena70@gmail.com
pubmed:publicationType
Journal Article, Review